Holen Sie sich die Stockscreener-App
15.73
0.38%
-0.06
Handel nachbörslich:
15.88
0.15
+0.95%
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
What is Lifesci Capital’s Forecast for CNTA Q3 Earnings? - Defense World
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Wellington Management Group LLP Has $1.94 Million Stock Position in The Campbell’s Company $CPB - Defense World
HighTower Advisors LLC Raises Holdings in Onto Innovation Inc. $ONTO - Defense World
American Century Companies Inc. Increases Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
American Century Companies Inc. Buys 83,678 Shares of AdvanSix $ASIX - Defense World
American Century Companies Inc. Increases Position in Mizuho Financial Group, Inc. $MFG - Defense World
Russell Investments Group Ltd. Invests $3.27 Million in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
FY2025 Earnings Estimate for CNTA Issued By Chardan Capital - Defense World
Equities Analysts Issue Forecasts for CNTA FY2025 Earnings - Defense World
Centessa Pharma general counsel sells $103k in shares By Investing.com - Investing.com South Africa
Centessa Pharma general counsel sells $103k in shares - Investing.com India
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 - Placera.se
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 - GlobeNewswire Inc.
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Bank of New York Mellon Corp Buys Shares of 10,257 Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) - Defense World
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA): On Track To A Higher Share Price - stocksregister.com
The Future of Centessa Pharmaceuticals plc ADR: Analyzing CNTA - investchronicle.com
Centessa Pharma (CNTA) CBO Weinhoff sells $155,598 in shares By Investing.com - Investing.com India
Centessa Pharma (CNTA) CBO Weinhoff sells $155,598 in shares - Investing.com
Cerity Partners LLC Invests $471,000 in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) - Defense World
Centessa Pharmaceuticals plc ADR Inc. (CNTA) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
Taseko Mines Ltd: Navigating Market Fluctuations with a 1.09B Market Cap - investchronicle.com
Codere Online Luxembourg (NASDAQ:CDRO) & Take-Two Interactive Software (NASDAQ:TTWO) Critical Analysis - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Buy” by Analysts - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% After Insider Selling - Defense World
Centessa Pharma (CNTA) CBO Weinhoff sells $138k in shares - Investing.com
Centessa Pharma CEO Saha sells $694,826 in shares - Investing.com
Ethiopia and Morocco Launch Joint Military Commission - Defense World
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Centessa Gets US FDA's Clearance to Start Phase 1 Trial of ORX142 for Neurological, Neurodegenerative Disorders - MarketScreener
Centessa Pharmaceuticals plc Announces Clearance of Investigational New Drug Application for ORX142 - MarketScreener
SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest - Quantisnow
Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet - MSN
Centessa Pharmaceuticals Announces Executive Changes By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals Announces Executive Changes - Investing.com India
Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss - marketscreener.com
Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M - marketscreener.com
Is Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) A Suitable Stock For New Investors Today? - Stocksregister
Ratios in Focus: Analyzing Centessa Pharmaceuticals plc ADR (CNTA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX
Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News
Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX
Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX
Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com
Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater
Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com
Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener
Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com
Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India
Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register
Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com
Centessa Pharmaceuticals officer Tia Bush sells $185,406 in shares - Investing.com
Centessa Pharmaceuticals chief business officer sells shares worth $193,429 - Investing.com
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):